199 related articles for article (PubMed ID: 26891034)
1. Identification of sirtuin 1 as a promising therapeutic target for hypertrophic scars.
Bai XZ; Liu JQ; Yang LL; Fan L; He T; Su LL; Shi JH; Tang CW; Zheng Z; Hu DH
Br J Pharmacol; 2016 May; 173(10):1589-601. PubMed ID: 26891034
[TBL] [Abstract][Full Text] [Related]
2. Adipose tissue-derived stem cells suppress hypertrophic scar fibrosis via the p38/MAPK signaling pathway.
Li Y; Zhang W; Gao J; Liu J; Wang H; Li J; Yang X; He T; Guan H; Zheng Z; Han S; Dong M; Han J; Shi J; Hu D
Stem Cell Res Ther; 2016 Aug; 7(1):102. PubMed ID: 27484727
[TBL] [Abstract][Full Text] [Related]
3. Cryptotanshinone downregulates the profibrotic activities of hypertrophic scar fibroblasts and accelerates wound healing: A potential therapy for the reduction of skin scarring.
Li Y; Shi S; Gao J; Han S; Wu X; Jia Y; Su L; Shi J; Hu D
Biomed Pharmacother; 2016 May; 80():80-86. PubMed ID: 27133042
[TBL] [Abstract][Full Text] [Related]
4. Exosome from adipose-derived mesenchymal stem cells attenuates scar formation through microRNA-181a/SIRT1 axis.
Chen J; Yu W; Xiao C; Su N; Han Y; Zhai L; Hou C
Arch Biochem Biophys; 2023 Sep; 746():109733. PubMed ID: 37652148
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-192 regulates hypertrophic scar fibrosis by targeting SIP1.
Li Y; Zhang J; Zhang W; Liu Y; Li Y; Wang K; Zhang Y; Yang C; Li X; Shi J; Su L; Hu D
J Mol Histol; 2017 Dec; 48(5-6):357-366. PubMed ID: 28884252
[TBL] [Abstract][Full Text] [Related]
6. Exosomes derived from human adipose mesenchymal stem cells attenuate hypertrophic scar fibrosis by miR-192-5p/IL-17RA/Smad axis.
Li Y; Zhang J; Shi J; Liu K; Wang X; Jia Y; He T; Shen K; Wang Y; Liu J; Zhang W; Wang H; Zheng Z; Hu D
Stem Cell Res Ther; 2021 Mar; 12(1):221. PubMed ID: 33789737
[TBL] [Abstract][Full Text] [Related]
7. Loureirin B inhibits fibroblast proliferation and extracellular matrix deposition in hypertrophic scar via TGF-β/Smad pathway.
Bai X; He T; Liu J; Wang Y; Fan L; Tao K; Shi J; Tang C; Su L; Hu D
Exp Dermatol; 2015 May; 24(5):355-60. PubMed ID: 25683490
[TBL] [Abstract][Full Text] [Related]
8. [Effects of silencing Smad ubiquitination regulatory factor 2 on the function of human hypertrophic scar-derived fibroblasts].
Zhang Z; Kuang F; Liu CL; Chen B; Tang WB; Li XJ
Zhonghua Shao Shang Za Zhi; 2017 Mar; 33(3):145-151. PubMed ID: 28316163
[No Abstract] [Full Text] [Related]
9. Salvianolic Acid B Attenuates Hypertrophic Scar Formation In Vivo and In Vitro.
Chong CH; Sun JM; Liu YX; Tsai YT; Zheng DN; Zhang YF; Yu L
Aesthetic Plast Surg; 2023 Aug; 47(4):1587-1597. PubMed ID: 36810832
[TBL] [Abstract][Full Text] [Related]
10. Triamcinolone acetonide suppressed scar formation in mice and human hypertrophic scar fibroblasts in a dose-dependent manner.
Wu Z; Huang D; Xie J; Li M; Chen P; Yu Z
Cell Mol Biol (Noisy-le-grand); 2023 Aug; 69(8):226-231. PubMed ID: 37715376
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol Activated Sonic Hedgehog Signaling to Enhance Viability of NIH3T3 Cells in Vitro via Regulation of Sirt1.
Guo S; Liao H; Liu J; Liu J; Tang F; He Z; Li Y; Yang Q
Cell Physiol Biochem; 2018; 50(4):1346-1360. PubMed ID: 30355933
[TBL] [Abstract][Full Text] [Related]
12. Loureirin B Inhibits Hypertrophic Scar Formation via Inhibition of the TGF-β1-ERK/JNK Pathway.
He T; Bai X; Yang L; Fan L; Li Y; Su L; Gao J; Han S; Hu D
Cell Physiol Biochem; 2015; 37(2):666-76. PubMed ID: 26344923
[TBL] [Abstract][Full Text] [Related]
13. Wnt4 negatively regulates the TGF-β1-induced human dermal fibroblast-to-myofibroblast transition via targeting Smad3 and ERK.
Liu J; Zhao B; Zhu H; Pan Q; Cai M; Bai X; Li X; Hu X; Zhang M; Shi J; Zheng Z; Yang A; Hu D
Cell Tissue Res; 2020 Mar; 379(3):537-548. PubMed ID: 31776823
[TBL] [Abstract][Full Text] [Related]
14. [Influences of human dermis derived mesenchymal stem cells on α-SMA and DCN expressions of hypertrophic scars fibroblasts].
Zhang W; Deng C; Guo C; Nie K; Tang X; Wei Z; Wang D
Zhonghua Zheng Xing Wai Ke Za Zhi; 2016 Jul; 32(4):285-92. PubMed ID: 30044575
[TBL] [Abstract][Full Text] [Related]
15. Sirt1 ameliorates systemic sclerosis by targeting the mTOR pathway.
Zhu X; Chu H; Jiang S; Liu Q; Liu L; Xue Y; Zheng S; Wan W; Qiu J; Wang J; Zou H
J Dermatol Sci; 2017 Aug; 87(2):149-158. PubMed ID: 28532580
[TBL] [Abstract][Full Text] [Related]
16. Protection against TGF-β1-induced fibrosis effects of IL-10 on dermal fibroblasts and its potential therapeutics for the reduction of skin scarring.
Shi JH; Guan H; Shi S; Cai WX; Bai XZ; Hu XL; Fang XB; Liu JQ; Tao K; Zhu XX; Tang CW; Hu DH
Arch Dermatol Res; 2013 May; 305(4):341-52. PubMed ID: 23321694
[TBL] [Abstract][Full Text] [Related]
17. The Histone Deacetylase Sirtuin 1 Is Reduced in Systemic Sclerosis and Abrogates Fibrotic Responses by Targeting Transforming Growth Factor β Signaling.
Wei J; Ghosh AK; Chu H; Fang F; Hinchcliff ME; Wang J; Marangoni RG; Varga J
Arthritis Rheumatol; 2015 May; 67(5):1323-34. PubMed ID: 25707573
[TBL] [Abstract][Full Text] [Related]
18. Normal skin and hypertrophic scar fibroblasts differentially regulate collagen and fibronectin expression as well as mitochondrial membrane potential in response to basic fibroblast growth factor.
Song R; Bian HN; Lai W; Chen HD; Zhao KS
Braz J Med Biol Res; 2011 May; 44(5):402-10. PubMed ID: 21445528
[TBL] [Abstract][Full Text] [Related]
19. Extracellular vesicles from Lactobacillus druckerii inhibit hypertrophic scar fibrosis.
Han F; Wang K; Shen K; Wang J; Han S; Hu D; Wu G
J Nanobiotechnology; 2023 Mar; 21(1):113. PubMed ID: 36978136
[TBL] [Abstract][Full Text] [Related]
20. The Effects of the Transforming Growth Factor-β1 (TGF-β1) Signaling Pathway on Cell Proliferation and Cell Migration are Mediated by Ubiquitin Specific Protease 4 (USP4) in Hypertrophic Scar Tissue and Primary Fibroblast Cultures.
Huang Y; Wang Y; Wang X; Lin L; Wang P; Sun J; Jiang L
Med Sci Monit; 2020 Apr; 26():e920736. PubMed ID: 32308208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
